Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alisha M. Monnette"'
Autor:
Nicholas J. Vogelzang, Nicholas J. Robert, Nizar M. Tannir, Yunfei Wang, Alisha M. Monnette, Yin Wan
Publikováno v:
Kidney Cancer. 5:189-197
BACKGROUND: Lenvatinib with everolimus (“Len/Eve”) is approved for advanced/metastatic RCC following one antiangiogenic therapy. OBJECTIVE: This study evaluated patient characteristics, treatment patterns and overall survival (OS) with second-lin
Autor:
Yunfei Wang, Yin Wan, Nicholas J. Vogelzang, Yiqiong Xie, Nicholas J. Robert, Alisha M. Monnette, Nizar M. Tannir
Publikováno v:
Clinical Genitourinary Cancer. 19:531-539
Introduction Few studies have evaluated real-world effectiveness of lenvatinib (Len)/everolimus (Eve) for advanced/metastatic renal cell carcinoma (a/mRCC). This study evaluated patient profiles and clinical outcomes of second- and subsequent-line (
Autor:
Yilu Lin, James E Bailey, Satya Surbhi, Sohul A Shuvo, Christopher D Jackson, Ming Chen, Eboni G Price-Haywood, Joshua Mann, Daniel Fort, Jeffrey Burton, Ramona Sandlin, Alexandra Castillo, Hao Mei, Patti Smith, Cardella Leak, Phi Le, Alisha M Monnette, Lizheng Shi
BACKGROUND Obesity affects nearly half of adults in the United States and is contributing substantially to a pandemic of obesity-associated chronic conditions such as type 2 diabetes, hypertension, and arthritis. The obesity-associated chronic condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c89cfc2d9a51f390f7a587a784b571
https://doi.org/10.2196/preprints.20788
https://doi.org/10.2196/preprints.20788